Table 3.
Variables | PC group (n = 161 patients) | CC group (n = 161 patients) | p value |
---|---|---|---|
Ventricular arrhythmia | 7 (6.7%) | 12 (12.1%) | 0.18 |
Aortic | 0 (0%) | 0 (0%) | 1 |
PM implantation | 3 (2.9%) | 3 (2.9%) | 1 |
Gastrointestinal complicationsa | 1 (1%) | 2 (1.9%) | 1 |
Pulmonary embolism | 0 (0%) | 0 (0%) | 1 |
Atrial fibrillation | 48 (45.7%) | 39 (39.4%) | 0.36 |
AMI | 1 (1%) | 1 (1%) | 1 |
Sternal wound infection | 0 (0%) | 0 (0%) | 1 |
Lower limb ischemia | 0 (0%) | 0 (0%) | 1 |
MOF | 1 (1%) | 1 (1%) | 1 |
Pneumonia | 2 (1.9%) | 1 (1%) | 1 |
Inguinal wound reintervention | 4 (3.8%) | 0 (0%) | 0.19 |
Deep venous thrombosis | 1 (1%) | 0 (0%) | 1 |
Re‐exploration for bleeding | 10 (29.2%) | 4 (3.7%) | 0.10 |
Sepsis | 2 (1.9%) | 2 (1.9%) | 1 |
Stroke | 2 (1.9%) | 1 (1%) | 1 |
Acute kidney injury | 39 (37, 14%) | 44 (44, 44%) | 0.2856 |
Exitus | 1 (1%) | 0 (0%) | 1 |
MACCE | 4 2.4%) | 2 (1.9%) | 0.49 |
Total bleeding | 532 (377; 762) | 480 (335; 770) | 0.03 |
Creatinine peak | 1 (0.8; 1.2) | 0.7 (0.8; 1.2) | 0.13 |
Intubation time (hours) | 4 (3; 6) | 4 (3; 5) | 0.32 |
ICU stay (days) | 2 (2; 3) | 2 (2; 3) | 0.16 |
Beta‐blockers | 44 (41.9%) | 40 (50.5%) | 0.82 |
Antiarrhythmic drugs | 11 (10.5%) | 13 (13.13%) | 0.55 |
Hospital stay (days) | 13 (9; 17) | 13 (10; 15) | 0.95 |
Abbreviations: AMI, acute myocardial infarction; ICU, intensive care unit; MACCE, major adverse cardiac and cerebrovascular events; MOF, multi organ failure; PM, pace maker.
Gastrointestinal complications include: pancreatitis, liver dysfunction, bowel ischaemia.